I am a specialist in biotech
due-diligence and competitor analysis.

Dr. Dan Palmer BSc BA PhD MBA FRSC CChem

I founded Proficit Partners to support biotech SMEs with first-class consulting, research and problem solving.

My own research focuses on cancer
immuno-metabolism
&
auto-immune disease aetiologies.

More about me

I’ve spent most of my 20-year career in R&D management in biotech SMEs, developing platform technologies and many therapeutic applications.

Though I have a broad science background, much of my work has been focused on drug delivery science, polymers & biomaterials and nanotechnologies for oncology or auto-immunity.

I have managed interdisciplinary R&D across biology, chemistry and engineering, and work at the interface of SMEs, academia and large-cap pharma. I’ve also worked in intellectual property management and strategy for the last 15 years and I am an inventor on >20 international patent families.

  • Principal Consultant, Proficit Partners, UK – 2016
  • Chief Scientific Officer, Midatech Pharma PLC, UK – 2014
  • Managing Director, Q Chip Ltd, Cardiff, UK – 2013
  • Chief Scientific Officer, Q Chip Ltd, Cardiff, UK – 2010

Imperial College Business School: Executive MBA (2012-2014)

  • Specialism in technology, strategy and entrepreneurship.
  • Further studies in sustainability, corporate finance, mergers & acquisitions, marketing, economics and accountancy

 

Heriot-Watt University, Edinburgh: PhD. in Chemistry (2000-2003)

  • CASE award sponsored by Syngenta PLC with industrial placement at Syngenta, Grangemouth – transition metal catalysis for industrial carbonylation reactions

 

Heriot-Watt University, Edinburgh: BSc (Hons) in Chemistry (1996-2000)

  • Included ERASMUS research placement at Julius Maximillian Universität, Würzburg, Germany working on complex organic synthesis & cyclo-addition chemistry
  • I became a Fellow of the Royal Society of Chemistry in 2014 and a Chartered Chemist in 2010.
  • Winner of the Imperial College Business School 2014 award for best Executive MBA thesis.
  • I was awarded Cardiff University’s 2010 Innovation Award for research into novel stem-cell culture systems.